drugset
drugset / Trial / NCT01035385

Compare FOFLOX4 in Preoperative and Postoperative and Postoperative in Resectable Liver Metastasis Colorectal Cancer (MCC)

NCT01035385 ↗

Phase 3 Unknown 340 enrolled Guangdong Provincial People's Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is a multicenter, open-label, randomized ,controlled phase III study to compare preoperative and postoperative with FOFLOX4 chemotherapy and postoperative with FOFLOX4 chemotherapy in patients with resectable liver metastasis from colorectal cancer.

Timeline

Start
2009-09
Primary completion
2012-10
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxaliplatin Small molecule 85 mg/m2 Intravenous
Subject calcium leucovorin Unknown 200 mg/m2 Intravenous
Subject fluorouracil Small molecule 400 mg/m2 Intravenous
Subject fluorouracil Small molecule 600 mg/m2 Intravenous

Indications

metastasis from malignant tumor of colon